Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 47 Records) |
| Query Trace: Lung Neoplasms and CD4[original query] |
|---|
| The T cell differentiation landscape is shaped by tumour mutations in lung cancer. Nature cancer 2020 8 1 (5): 546-561. Ghorani Ehsan, Reading James L, Henry Jake Y, Massy Marc Robert de, Rosenthal Rachel, Turati Virginia, Joshi Kroopa, Furness Andrew J S, Ben Aissa Assma, Saini Sunil Kumar, Ramskov Sofie, Georgiou Andrew, Sunderland Mariana Werner, Wong Yien Ning Sophia, Mucha Maria Vila De, Day William, Galvez-Cancino Felipe, Becker Pablo D, Uddin Imran, Oakes Theres, Ismail Mazlina, Ronel Tahel, Woolston Annemarie, Jamal-Hanjani Mariam, Veeriah Selvaraju, Birkbak Nicolai J, Wilson Gareth A, Litchfield Kevin, Conde Lucia, Guerra-Assunção José Afonso, Blighe Kevin, Biswas Dhruva, Salgado Roberto, Lund Tom, Bakir Maise Al, Moore David A, Hiley Crispin T, Loi Sherene, Sun Yuxin, Yuan Yinyin, AbdulJabbar Khalid, Turajilic Samra, Herrero Javier, Enver Tariq, Hadrup Sine R, Hackshaw Allan, Peggs Karl S, McGranahan Nicholas, Chain Benny, , Swanton Charles, Quezada Sergio |
| A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma. Journal of translational medicine 2020 3 18 (1): 123. Guo Dina, Wang Mian, Shen Zhihong, Zhu Jiao |
| Immune microenvironment features and efficacy of PD-1/PD-L1 blockade in non-small cell lung cancer patients with EGFR or HER2 exon 20 insertions. Thoracic cancer 2020 11 12 (2): 218-226. Chen Kaiyan, Pan Guoqiang, Cheng Guoping, Zhang Fanrong, Xu Yanjun, Huang Zhiyu, Fan Y |
| Predicting the Clinical Outcome of Lung Adenocarcinoma Using a Novel Gene Pair Signature Related to RNA-Binding Protein. BioMed research international 2020 11 2020 8896511. Meng Liangliang, He Xiaoxi, Zhang Xiao, Zhang Xiaobo, Wei Yingtian, Wu Bin, Li Jing, Xiao Yueyo |
| Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival. Frontiers in immunology 2020 11 1933. Chen Rui-Lian, Zhou Jing-Xu, Cao Yang, Sun Ling-Ling, Su Shan, Deng Xiao-Jie, Lin Jie-Tao, Xiao Zhi-Wei, Chen Zhuang-Zhong, Wang Si-Yu, Lin Li-Z |
| Metatranscriptomic Analysis of Human Lung Metagenomes from Patients with Lung Cancer. Genes 2021 Sep 12 (9): . Chang Ya-Sian, Hsu Ming-Hung, Tu Siang-Jyun, Yen Ju-Chen, Lee Ya-Ting, Fang Hsin-Yuan, Chang Jan-Gow |
| Prognosis of Non-small-cell Lung Cancer Patients With Lipid Metabolism Pathway Alternations to Immunotherapy. Frontiers in genetics 2021 12 646362. Cheng Tianli, Zhang Jing, Liu Danni, Lai Guorong, Wen Xiaopi |
| Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer. The Journal of pathology 2021 8 255 (3): 243-256. Backman Max, La Fleur Linnéa, Kurppa Pinja, Djureinovic Dijana, Elfving Hedvig, Brunnström Hans, Mattsson Johanna Sofia Margareta, Lindberg Amanda, Pontén Victor, Eltahir Mohamed, Mangsbo Sara, Gulyas Miklos, Isaksson Johan, Jirström Karin, Kärre Klas, Leandersson Karin, Mezheyeuski Artur, Pontén Fredrik, Strell Carina, Lindskog Cecilia, Botling Johan, Micke Patri |
| KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials. Frontiers in oncology 2021 11 659200. Zhu Hongyuan, Xie Daipeng, Yu Yunfang, Yao Lintong, Xu Bin, Huang Luyu, Wu Shaowei, Li Fasheng, Zheng Yating, Liu Xinyi, Xie Wenzhuan, Huang Mengli, Li Hao, Zheng Shaopeng, Zhang Dongkun, Qiao Guibin, Chan Lawrence W C, Zhou Hai |
| Tumor Purity Coexpressed Genes Related to Immune Microenvironment and Clinical Outcomes of Lung Adenocarcinoma. Journal of oncology 2021 2021 9548648. Bai Ming, Pan Qi, Sun Ch |
| A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma. Oncogene 2021 Jun . Wu Jie, Li Lan, Zhang Huibo, Zhao Yaqi, Zhang Haohan, Wu Siyi, Xu B |
| Co-Occurring Alteration of NOTCH and DDR Pathways Serves as Novel Predictor to Efficacious Immunotherapy in NSCLC. Frontiers in oncology 2021 5 11 659321. Zhang Zhimin, Gu Yanyan, Su Xiaona, Bai Jing, Guan Wei, Ma Jungang, Luo Jia, He Juan, Zhang Bicheng, Geng Mingying, Xia Xuefeng, Guan Yanfang, Shen Cheng, Chen Chu |
| The Relationship between Lymphocyte Subsets and the Prognosis and Genomic Features of Lung Cancer: A Retrospective Study. International journal of medical sciences 2021 4 18 (10): 2228-2234. Dai Shuiping, Ren Pengwei, Ren Jing, Yang Lan, Li Weim |
| Characteristics of T-Cell Receptor Repertoire and Correlation With EGFR Mutations in All Stages of Lung Cancer. Frontiers in oncology 2021 3 11 537735. Yang Huaxia, Wang Yadong, Jia Ziqi, Wang Yanyu, Yang Xiaoying, Wu Pancheng, Song Yang, Xu Huihui, Gu Dejian, Chen Rongrong, Xia Xuefeng, Bing Zhongxing, Gao Chao, Cao Lei, Li Shanqing, Cao Zhili, Liang Naix |
| PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung. Cancer immunology, immunotherapy : CII 2021 2 70 (9): 2577-2587. Goldmann Torsten, Marwitz Sebastian, Nitschkowski Dörte, Krupar Rosemarie, Backman Max, Elfving Hedvig, Thurfjell Viktoria, Lindberg Amanda, Brunnström Hans, La Fleur Linnea, Mezheyeuski Artur, Mattsson Johanna Sofia Margareta, Botling Johan, Micke Patrick, Strell Cari |
| Evaluation Expression of miR-146a and miR-155 in Non-Small-Cell Lung Cancer Patients. Frontiers in oncology 2021 11 11 715677. Dezfuli Neda K, Alipoor Shamila D, Dalil Roofchayee Neda, Seyfi Sharareh, Salimi Babak, Adcock Ian M, Mortaz Esmae |
| Construction of a redox-related gene signature for overall survival prediction and immune infiltration in non-small-cell lung cancer. Frontiers in molecular biosciences 2022 9 9 942402. Miao Ti-Wei, Yang De-Qing, Gao Li-Juan, Yin Jie, Zhu Qi, Liu Jie, He Yan-Qiu, Chen X |
| Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment. Lung cancer (Amsterdam, Netherlands) 2022 8 172 19-28. Akhave Neal, Zhang Jiexin, Bayley Erin, Frank Meredith, Chiou Shin-Heng, Behrens Carmen, Chen Runzhe, Hu Xin, Parra Edwin Roger, Lee Won-Chul, Swisher Stephen, Solis Luisa, Weissferdt Annikka, Moran Cesar, Kalhor Neda, Zhang Jianhua, Scheet Paul, Vaporciyan Ara A, Sepesi Boris, Gibbons Don L, Heymach John V, Lee Jack J, Wistuba Ignacio I, Andrew Futreal P, Zhang Jianjun, Fujimoto Junya, Reuben Alexand |
| HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade. Annals of oncology : official journal of the European Society for Medical Oncology 2022 3 33 (7): 728-738. Shao X M, Huang J, Niknafs N, Balan A, Cherry C, White J, Velculescu V E, Anagnostou V, Karchin |
| Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell Lung Cancer. Cancer control : journal of the Moffitt Cancer Center 0 29 10732748221076682. Feng Zhenxing, Yin Yan, Liu Bin, Zheng Yafang, Shi Dongsheng, Zhang Hong, Qin Jianw |
| An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy. Frontiers in immunology 2022 12 13 1022598. Lin Jing, Liu Jun, Hao Shi-Guang, Lan Bin, Zheng Xiao-Bin, Xiong Jia-Ni, Zhang Ying-Qian, Gao Xuan, Chen Chuan-Ben, Chen Ling, Huang Yu-Fang, Luo Hong, Yi Yu-Ting, Yi Xin, Lu Jian-Ping, Zheng Xiong-Wei, Chen Gang, Wang Xue-Feng, Chen |
| Non?small cell lung cancer carrying PBRM1 mutation suggests an immunologically cold phenotype leading to immunotherapy failure even with high TMB. Scientific reports 2022 12 12 (1): 20734. Miao Xia-Ye, Wu Hao, Ye Bi-Cheng, Yi Qian-Wen, Lin Fang-Nan, Wang Yi-Lin, Ren Chuan-Li, Jiang Yan-Fang, Li A |
| Study on PD-L1 Expression in NSCLC Patients and Related Influencing Factors in the Real World. Computational and mathematical methods in medicine 2022 1 2021 3273347. Zhu Yefei, Lin Shuangxiang, Wang Yueping, Shen Bingxiao, Lin Ling, Wang Liangxing, He Su |
| Uses of Vascular Endothelial Growth Factor C as a Lung Adenocarcinoma Prognostic Biomarker. World journal of oncology 2023 3 14 (1): 51-59. Chen Shi, Pan Ting Yu, Wu Xiao, Li Tian, Wei Yu, He Hai Lang, Zhou Xian Mei, Wang Qian, Zhu Ji Pi |
| Development and Validation of a Prognosis-Prediction Signature for Patients with Lung Adenocarcinoma Based on 11 Telomere-Related Genes. Frontiers in bioscience (Landmark edition) 2023 11 28 (10): 254. Jia Liu, Sha Sha, Jian Wang, Xiaowei Gu, Menghua Du, Xu |
| CCR5 promoter polymorphisms associated with nonsmall cell lung cancer. International journal of immunogenetics 2023 11 . Tianchang Lu, Yuhan Shi, Minyi Wang, Weipeng Liu, Yang Cao, Li Shi, Qianli Ma, Shuyuan L |
| Analysis of genomic and immune intratumor heterogeneity in linitis plastica via multiregional exome and T-cell receptor sequencing. Molecular oncology 2023 1 . Huang Jin, Zhao Guofeng, Peng Qiu, Yi Xin, Ji Liyan, Li Jing, Li Pansong, Guan Yanfang, Ge Jie, Chen Ling, Chen Runzhe, Hu Xin, Lee Won-Chul, Reuben Alexandre, Futreal P Andrew, Xia Xuefeng, Ma Jian, Zhang Jianjun, Chen Zih |
| Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung Cancer. Clinical lung cancer 2024 6 . Rachel L Minne, Natalie Y Luo, Anne M Traynor, Minxuan Huang, Luisina DeTullio, Jen Godden, Melissa Stoppler, Randall J Kimple, Andrew M Baschnag |
| The causal role of immune cells on lung cancer: a bi-directional Mendelian randomization (MR) study. Aging 2024 6 16 . Hongyu Zhu, Caihua Chen, Haixie Guo, Bo Zhang, Quanteng |
| Multi-index comprehensive evaluation of the efficacy and response mechanism of immunotherapy in non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 6 . Jieqiong Fan, Tao Zha |
- Page last reviewed:Feb 1, 2024
- Content source: